The following list is of recent intellectual property trials in the Federal Court. For upcoming trials, see the trial hearing list.
This list is automatically generated and has not been verified.
Automatically generated on September 26, 2024.
2024
- Proslide Technology, Inc. v. Whitewater West Industries, Ltd.
T-1449-20 – Patent Infringement
2024-06-17 for 10 d (Toronto)
Post-trial decisions: 2024 FC 1439 (Manson)
Interlocutory decisions: 2023 FC 1591 (Crinson), 2024 FC 175 (Manson)
- BOEHRINGER INGELHEIM(CANADA) LTD ET AL v. JAMP PHARMA CORP.
T-1563-22 – Patented Medicines (NOC) Regulations [Actions] – Nintedanib
2024-05-06 for 10 d (Toronto)
Post-trial decisions: 2024 FC 1198 (Furlanetto)
Interlocutory decisions: 2023 FC 1414 (Cotter), 2024 FC 656 (Furlanetto)
- GILEAD SCIENCES, INC. ET AL. v. NATCO PHARMA (CANADA), INC.
T-1555-22 – Patented Medicines (NOC) Regulations [Actions] – Tenofovir
2024-04-08 for 2 d (Toronto)
Discontinuance filed during trial.
- GILEAD SCIENCES, INC. ET AL. v. NATCO PHARMA (CANADA) INC.
T-1556-22 – Patented Medicines (NOC) Regulations [Actions] – Tenofovir
2024-04-08 for 2 d (Toronto)
Discontinuance filed during trial.
- THE ESTATE OF VIVIAN MAIER v. STEPHEN M.BULGER ET AL.
T-953-17 – Copyright Infringement [Actions]
2024-03-04 for 5 d (Toronto)
Post-trial decisions: 2024 FC 1267 (Furlanetto)
Interlocutory decisions: 2024 FC 183 (Furlanetto)
2023
- JCAI INC. v. WISELEAP SOLUTIONS INC. et al
T-1386-21 – Patent Infringement
2023-11-20 for 12 d (Montréal)
Waiting for trial decision from trial judge, Justice McHaffie.
- TAKEDA CANADA v. APOTEX, TAKEDA PHARMACEUTICAL CO & TAKEDA PHARMA USA
T-151-22 – Patented Medicines (NOC) Regulations [Actions] – Dexlansoprazole
2023-10-16 for 10 d (Toronto) and 2023-11-08 for 2 d (Toronto)
Post-trial decisions: 2023 FC 1366 (Furlanetto), 2024 FC 106 (Furlanetto)
Interlocutory decisions: 2023 FC 63 (Tabib), 2023 FC 1353 (Furlanetto)
- ALLERGAN, INC. ET AL. v. JUNO PHARMACEUTICALS CORP.
T-1994-21 – Patented Medicines (NOC) Regulations [Actions] – Bimatoprost
2023-09-11 for 10 d (Toronto) and 2023-09-27 for 2 d (Toronto)
Post-trial decisions: 2023 FC 1686 (Pentney)
- STEELHEAD LNG (ASLNG) LTD ET AL. v. SEVEN GENS ENERGY LTD, ROCKIES LNG ET AL
T-1488-20 – Patent Infringement
2023-09-11 for 10 d (Toronto)
Post-trial decisions: 2023 FC 1684 (Manson)
Interlocutory decisions: 2022 FC 756 (McDonald), 2022 FC 998 (Manson)
- PHARMACYCLICS LLC et Al. v. NATCO PHARMA (CANADA) INC.
T-1472-21 – Patented Medicines (NOC) Regulations [Actions] – Ibrutinib
2023-07-05 for 6 d (Toronto)
Discontinuance filed during trial.
- PHARMACYCLICS LLC et Al. v. NATCO PHARMA (CANADA) INC.
T-1475-21 – Patented Medicines (NOC) Regulations [Actions] – Ibrutinib
2023-07-05 for 6 d (Toronto)
Discontinuance filed during trial.
- MOLO DESIGN, LTD. v. CHANEL CANADA ULC et Al.
T-379-21 – Patent Infringement
2023-06-05 for 10 d (Montréal)
Post-trial decisions: 2024 FC 1260 (McHaffie)
Interlocutory decisions: 2023 FC 140 (Tabib)
- WANAKOME INC. v. ERIC MARTIN ET AL.
T-609-20 – Trade Mark Infringement
2023-05-08 for 5 d (Montréal)
Post-trial decisions: 2024 FC 688 (Furlanetto)
- BELL CANADA ET AL v. WATCHNSAVENOW INC. ET AL
T-1924-17 – Copyright Infringement [Actions]
2023-05-08 for 2 d (Toronto)
Waiting for trial decision from trial judge, Justice Fuhrer.
- FROMFROID S.A. c. 1048547 ONTARIO INC. et al.
T-127-19 – Patent Infringement
2023-04-17 for 5 d (Montréal)
Post-trial decisions: 2023 FC 925 (Grammond), 2023 FC 1187 (Grammond)
- LEONARD B FRENCH v. THE ROYAL CANADIAN LEGION (DOMINION COMMAND)
T-1441-21 – Copyright Infringement [Actions]
2023-04-12 for 2 d (Vancouver)
Post-trial decisions: 2023 FC 749 (Manson)
- VIDÃ?OTRON LTÃ?E ET AL c. TECHNOLOGIES KONEK INC. ET AL
T-374-21 – Copyright Infringement [Actions]
2023-02-20 for 4 d (Montréal)
Post-trial decisions: 2023 FC 741 (Grammond), 2023 CF 1502 (Roy), 2023 FC 1162 (Grammond), 2023 FC 1164 (Grammond)
Interlocutory decisions: 2022 CF 256 (Grammond), 2022 CF 733 (Grammond)
- MEDEXUS PHARMACEUTICALS INC. ET AL. v. ACCORD HEALTHCARE INC. ET AL
T-1007-20 – Patent Infringement
2023-01-09 for 14 d (Toronto)
Post-trial decisions: 2024 FC 424 (Pallotta)
Interlocutory decisions: 2022 FC 1734 (Pallotta)
2022
- ABBVIE CORPORATION, ET AL v. JAMP PHARMA CORPORATION
T-557-21 – Patented Medicines (NOC) Regulations [Actions] – Adalimumab
2022-11-14 for 20 d (Toronto) and 2022-12-13 for 2 d (Toronto)
Post-trial decisions: 2023 FC 1520 (McVeigh)
- ABBVIE CORPORATION, ET AL v. JAMP PHARMA CORPORATION
T-559-21 – Patented Medicines (NOC) Regulations [Actions] – Adalimumab
2022-11-14 for 20 d (Toronto) and 2022-12-13 for 2 d (Toronto)
Discontinuance filed post trial.
- ABBVIE CORPORATION, ET AL v. JAMP PHARMA CORPORATION
T-560-21 – Patented Medicines (NOC) Regulations [Actions] – Adalimumab
2022-11-14 for 20 d (Toronto) and 2022-12-13 for 2 d (Toronto)
Discontinuance filed post trial.
- ABBVIE CORPORATION, ET AL v. JAMP PHARMA CORPORATION
T-561-21 – Patented Medicines (NOC) Regulations [Actions] – Adalimumab
2022-11-14 for 20 d (Toronto) and 2022-12-13 for 2 d (Toronto)
Post-trial decisions: 2023 FC 1520 (McVeigh)
- Jamp Pharma Corporation v. AbbVie Corporation et Al.
T-572-21 – Patent Impeachment – Adalimumab
2022-11-14 for 20 d (Toronto) and 2022-12-13 for 2 d (Toronto)
Discontinuance filed post trial.
- Jamp Pharma Corporation v. AbbVie Corporation et Al.
T-573-21 – Patent Impeachment – Adalimumab
2022-11-14 for 20 d (Toronto) and 2022-12-13 for 2 d (Toronto)
Post-trial decisions: 2023 FC 1520 (McVeigh)
- Jamp Pharma Corporation v. AbbVie Corporation et Al.
T-577-21 – Patent Impeachment – Adalimumab
2022-11-14 for 20 d (Toronto) and 2022-12-13 for 2 d (Toronto)
Post-trial decisions: 2023 FC 1520 (McVeigh)
- Jamp Pharma Corporation v. AbbVie Corporation et Al.
T-581-21 – Patent Impeachment – Adalimumab
2022-11-14 for 20 d (Toronto) and 2022-12-13 for 2 d (Toronto)
Discontinuance filed post trial.
- TEKNA PLASMA SYSTEMS INC. v. AP&C ADVANCED POWDERS & COATINGS INC.
T-126-19 – Patent Impeachment
2022-10-18 for 14 d (Montréal) and 2022-11-09 for 2 d (Montréal)
Post-trial decisions: 2024 FC 871 (McHaffie)
- VALLEY BLADES LTD v. USINAGE PRO-24 INC. c/o/b as NORDIK BLADES
T-1790-17 – Patent Infringement
2022-10-17 for 7 d (Ottawa)
Post-trial decisions: 2023 FC 1749 (St-Louis)
- USINAGE PRO-24 INC. v. VALLEY BLADES LTD
T-416-19 – Patent Infringement
2022-10-17 for 7 d (Ottawa)
Post-trial decisions: 2023 FC 1749 (St-Louis)
- TRAVEL LEADERS GROUP, LLC v. 2042923 ONTARIO INC. dba TRAVEL LEADERS
T-202-17 – Trade Mark Infringement
2022-09-12 for 10 d (Toronto)
Waiting for trial decision from trial judge, .
- FARMOBILE, LLC. v. FARMERS EDGE INC.
T-449-17 – Patent Infringement
2022-08-08 for 13.6 d (Vancouver) and 2022-09-15 for 1.7 d (Vancouver)
Post-trial decisions: 2024 FC 934 (McHaffie)
Interlocutory decisions: 2018 FC 915 (Ring), 2018 FC 1269 (Mactavish), 2020 CanLII 24172 (Ring), 2020 FC 688 (Ring), 2021 FC 1200 (Ring), 2021 FC 1427 (McHaffie), 2022 FC 22 (McHaffie)
- ARYSTA LIFESCIENCE NORTH AMERICA ET AL v. AGRACITY CROP ET AL
T-604-19 – Patent Infringement
2022-08-15 for 4 d (Calgary)
Post-trial decisions: 2022 FC 1422 (Aylen), 2023 FC 163 (Aylen)
Interlocutory decisions: 2019 FC 530 (Pentney), 2020 FC 388 (Pentney)
- JANSSEN INC. ET AL v. PHARMASCIENCE INC.
T-1441-20 – Patented Medicines (NOC) Regulations [Actions] – Paliperidone
2022-07-04 for 10 d (Toronto)
Post-trial decisions: 2022 FC 1218 (Manson), 2023 FC 912 (Manson), 2023 FC 1464 (Morgan)
Interlocutory decisions: 2022 FC 62 (Manson)
- Janssen Inc. et Al. v. Pharmascience Inc.
T-558-22 – Patented Medicines (NOC) Regulations [Actions] – Paliperidone
2022-07-04 for 10 d (Toronto)
Post-trial decisions: 2022 FC 1218 (Manson), 2023 FC 1464 (Morgan)
- GOOGLE LLC v. SONOS, INC.
T-952-20 – Patent Infringement
2022-06-13 for 10 d (Toronto)
Post-trial decisions: 2022 FC 1116 (Zinn)
Interlocutory decisions: 2021 FC 1462 (Southcott)
- JANSSEN INC. ET AL. v. JAMP PHARMA CORPORATION
T-769-20 – Patented Medicines (NOC) Regulations [Actions] – Macitentan
2022-04-04 for 8 d (Toronto)
Discontinuance filed during trial.
- CROCS CANADA, INC. AND CROCS INC. v. DOUBLE DIAMOND DISTRIBUTION LTD.
T-1662-17 – Trade Mark Infringement
2022-03-14 for 7.7 d (Winnipeg)
Post-trial decisions: 2022 FC 1445 (Fuhrer), 2022 FC 1443 (Fuhrer), 2023 FC 184 (Fuhrer)
- T-REX PROPERTY AB v. PATTISON OUTDOOR ADVERTISING LIMITED PARTNERSHIP ET AL
T-1066-17 – Patent Infringement
2022-02-23 for 13 d (Toronto)
Post-trial decisions: 2022 FC 1007 (Roy), 2022 FC 1008 (Roy)
Interlocutory decisions: 2019 FC 1004 (Manson)
- NCS MULTISTAGE INC. v. KOBOLD CORPORATION, ET AL
T-1420-18 – Patent Infringement
2022-01-12 for 26 d (Calgary) and 2022-02-28 for 2 d (Calgary)
Post-trial decisions: 2023 FC 1486 (McVeigh)
Interlocutory decisions: 2021 FC 1395 (Manson)
- JANSSEN INC. ET AL. v. APOTEX INC.
T-555-20 – Patented Medicines (NOC) Regulations [Actions] – Macitentan
2022-02-07 for 5 d (Toronto) and 2022-02-28 for 2 d (Toronto)
Post-trial decisions: 2022 FC 995 (Pallotta), 2022 FC 996 (Pallotta)
- NCS MULTISTAGE INC. v. PROMAC INDUSTRIES LTD.
T-567-20 – Patent Infringement
2022-01-12 for 26 d (Calgary) and 2022-02-28 for 2 d (Calgary)
Post-trial decisions: 2023 FC 1486 (McVeigh)
Interlocutory decisions: 2021 FC 1395 (Manson)
- JANSSEN INC. ET AL. v. SANDOZ CANADA INC.
T-549-20 – Patented Medicines (NOC) Regulations [Actions] – Macitentan
2022-01-24 for 7 d (Toronto) and 2022-02-17 for 2 d (Toronto)
Post-trial decisions: 2022 FC 715 (Pallotta)
Interlocutory decisions: T-549-20 (Pallotta)
- ENERGIZER BRANDS, LLC et al. v. THE GILLETTE COMPANY ET AL
T-1591-15 – Trade Mark Infringement
2022-01-10 for 10 d (Toronto)
Post-trial decisions: 2023 FC 804 (Fuhrer), 2024 FC 717 (Fuhrer)
Interlocutory decisions: 2018 FC 1003 (Brown)
- MERCK SHARP & DOHME CORP ET AL. v. PHARMASCIENCE INC.
T-419-20 – Patented Medicines (NOC) Regulations [Actions] – Sitagliptin
2022-01-10 for 10 d (Toronto)
Post-trial decisions: 2021 FC 1456 (Furlanetto), 2022 FC 417 (Furlanetto)
2021
- PHARMASCIENCE INC. v. MEDA AB ET AL
T-815-17 – PMNOC – Section 8 – Zolpidem
2021-11-15 for 8 d (Montréal)
Settlement post trial.
Interlocutory decisions: 2021 FC 1209 (Zinn), 2021 FC 1216 (Zinn)
- AUGUST IMAGE, LLC v. AIRG INC.
T-1443-18 – Copyright Infringement [Actions]
2021-11-01 for 2 d (Calgary)
Post-trial decisions: 2022 FC 470 (Tabib)
Interlocutory decisions: 2021 FC 272 (Mosley)
- PHARMASCIENCE INC. v. PFIZER CANADA ULC
T-1434-14 – PMNOC – Section 8 – Pregabalin
2021-07-19 for 5 d (Toronto) and 2021-08-03 for 4 d (Toronto) and 2021-08-12 for 2 d (Toronto)
Discontinuance filed post trial.
Interlocutory decisions: 2015 FC 1134 (Zinn), 2019 FC 1272 (O’Reilly), 2019 FC 1271 (O’Reilly), 2020 FC 1176 (O’Reilly), 2020 FC 1175 (O’Reilly)
- PAID SEARCH ENGINE TOOLS, LLC v. GOOGLE CANADA CORPORATION ET AL
T-40-18 – Patent Infringement
2021-06-14 for 13 d (Ottawa)
Post-trial decisions: 2021 FC 1435 (McDonald), 2022 FC 519 (McDonald)
Interlocutory decisions: 2019 FC 559 (Phelan), 2020 FC 992 (McVeigh), 2021 FC 515 (McDonald), 2021 FC 587 (McDonald)
- ANGELCARE DEVELOPMENT INC. ET AL. v. MUNCHKIN, INC ET AL.
T-151-16 – Patent Infringement
2021-01-25 for 30 d (Ottawa) and 2021-03-29 for 12 d (Ottawa) and 2021-04-27 for 3 d (Ottawa)
Post-trial decisions: 2021 FCA 169 (Locke), 2022 FC 507 (Roy), 2023 FC 1111 (Roy)
Interlocutory decisions: 2018 FC 447 (Roussel), 2020 FC 1185 (Roy), 2021 FC 238 (Roy)
- HOSPIRA HEALTHCARE CORPORATION v. THE KENNEDY INSTITUTE OF RHEUMATOLOGY
T-396-13 – Patent Impeachment – Infliximab
2016-09-12 for 15 d (Toronto) and 2016-10-17 for 2 d (Toronto) and 2017-01-17 for 2 d (Toronto) and 2020-01-27 for 8 d (Toronto) and 2021-02-01 for 5 d (Toronto) and 2021-03-08 for 10 d (Toronto) and 2021-03-29 for 2 d (Toronto)
Post-trial decisions: 2021 FC 42 (Phelan)
Interlocutory decisions: 2015 FC 1292 (Kane), 2016 FC 436 (Boswell), 2018 FC 259 (Phelan), 2018 FC 992 (Southcott), 2018 FC 1067 (Phelan), 2019 FC 1402 (Phelan), 2020 FC 827 (Phelan)
- HOFFMAN-LA ROCHE LIMITED ET AL. v. SANDOZ CANADA INC.
T-896-19 – Patented Medicines (NOC) Regulations [Actions] – Pirfenidone
2021-02-08 for 1.7 d (Toronto) and 2021-02-22 for 10.7 d (Toronto)
Post-trial decisions: 2021 FC 384 (Manson)
- HOFFMANN-LA ROCHE LIMITED ET AL v. SANDOZ CANADA INC.
T-897-19 – Patented Medicines (NOC) Regulations [Actions] – Pirfenidone
2021-02-08 for 1.7 d (Toronto) and 2021-02-22 for 10.7 d (Toronto)
Post-trial decisions: 2021 FC 384 (Manson)
- HOFFMAN-LA ROCHE LIMITED ET AL. v. SANDOZ CANADA INC.
T-898-19 – Patented Medicines (NOC) Regulations [Actions] – Pirfenidone
2021-02-08 for 1.7 d (Toronto) and 2021-02-22 for 10.7 d (Toronto)
Post-trial decisions: 2021 FC 384 (Manson)
- HOFFMAN-LA ROCHE LIMITED ET AL. v. SANDOZ CANADA INC.
T-899-19 – Patented Medicines (NOC) Regulations [Actions] – Pirfenidone
2021-02-08 for 1.7 d (Toronto) and 2021-02-22 for 10.7 d (Toronto)
Post-trial decisions: 2021 FC 384 (Manson)
- ALLERGAN INC. ET AL v. APOTEX INC.
T-794-19 – Patented Medicines (NOC) Regulations [Actions] – Risedronate
2021-02-01 for 9 d (Toronto) and 2021-03-02 for 2 d (Toronto)
Post-trial decisions: 2022 FC 260 (Kane)
- MILANO PIZZA LTD. v. 6034799 CANADA INC ET AL
T-152-17 – Trade Mark Infringement
2021-02-15 for 7 d (Ottawa)
Post-trial decisions: 2022 FC 425 (Fuhrer)
Interlocutory decisions: 2018 FC 1112 (Mactavish)
- ROVI GUIDES, INC. ET AL v. VIDEOTRON LTD.
T-921-17 – Patent Infringement
2020-03-09 for 5 d (Toronto) and 2020-05-25 for 5 d (Toronto) and 2020-06-08 for 10 d (Toronto) and 2021-01-20 for 3 d (Toronto)
Post-trial decisions: 2022 FC 874 (Lafrenière)
Interlocutory decisions: 2019 FC 1220 (Lafrenière), 2020 FC 596 (Lafrenière), 2020 FC 637 (Lafrenière), 2021 FC 19 (Lafrenière)
- ROVI GUIDES INC ET AL v. BCE INC. ET AL
T-113-18 – Patent Infringement
2020-07-13 for 19 d (Toronto) and 2021-01-14 for 2 d (Toronto)
Post-trial decisions: 2022 FC 1388 (Lafrenière)
- ROVI GUIDES, INC. ET AL v. TELUS CORPORATION ET AL
T-206-18 – Patent Infringement
2020-07-13 for 19 d (Toronto) and 2021-01-14 for 2 d (Toronto)
Post-trial decisions: 2022 FC 1388 (Lafrenière)
2020
- MERCK SHARP & DOHME CORP.ET AL v. WYETH LLC
T-1184-17 – Patent Impeachment – Pneumococcal
2020-11-30 for 10 d (Toronto) and 2020-12-21 for 2 d (Toronto)
Post-trial decisions: 2021 FC 317 (Gagné)
Interlocutory decisions: 2020 FC 1087 (Gagné)
- DEEPROOT GREEN INFRASTRUCTURE, LLC ET AL v. GREENBLUE URBAN NORTH AMERICA IN
T-954-18 – Patent Infringement
2020-10-13 for 13 d (Toronto) and 2020-12-17 for 2 d (Toronto)
Post-trial decisions: 2021 FC 501 (McDonald), 2021 FC 751 (McDonald), 2022 FC 709 (McDonald)
- BAUER HOCKEY LTD. v. SPORT MASKA INC. dba REEBOK-CCM HOCKEY
T-311-12 – Trade Mark Infringement
2020-12-03 for 14 d (Montréal)
Discontinuance filed post trial.
Interlocutory decisions: 2018 FC 1143 (Tabib), 2020 FC 1123 (Grammond)
- MAOZ BETSER-ZILEVITCH v. PETROCHINA CANADA LTD.
T-1158-18 – Patent Infringement
2020-11-30 for 12 d (Toronto)
Post-trial decisions: 2021 FC 85 (Manson), 2021 FC 151 (Manson)
- DTECHS EPM LTD. v. BRITISH COLUMBIA HYDRO AND POWER AUTHORITY et al.
T-227-17 – Patent Infringement
2020-11-16 for 10 d (Vancouver)
Post-trial decisions: 2021 FC 190 (Fothergill), 2021 FC 357 (Fothergill), 2023 FC 1446 (Morgan), 2023 FC 1460 (Morgan)
Interlocutory decisions: 2019 FC 539 (Lafrenière)
- LICKERISH, LTD. v. AIRG INC.
T-168-18 – Copyright Infringement [Actions]
2020-11-17 for 3 d (Ottawa)
Post-trial decisions: 2020 FC 1128 (Aylen)
- JANSSEN INC. ET AL. v. PHARMASCIENCE INC.
T-182-19 – Patented Medicines (NOC) Regulations [Actions] – Abiraterone
2020-10-26 for 20 d (Toronto)
Post-trial decisions: 2021 FC 5 (Phelan), 2021 FC 7 (Phelan)
- JANSSEN INC. ET AL. v. PHARMASCIENCE INC.
T-1893-19 – Patented Medicines (NOC) Regulations [Actions] – Abiraterone
2020-10-26 for 20 d (Toronto)
Post-trial decisions: 2021 FC 6 (Phelan), 2021 FC 7 (Phelan)
- JANSSEN INC. ET AL. v. APOTEX INC.
T-84-19 – Patented Medicines (NOC) Regulations [Actions] – Abiraterone
2020-10-26 for 20 d (Toronto)
Post-trial decisions: 2021 FC 3 (Phelan), 2021 FC 7 (Phelan)
- JANSSEN INC. ET AL v. DR. REDDY’S LABORATORIES LTD. ET AL
T-978-19 – Patented Medicines (NOC) Regulations [Actions] – Abiraterone
2020-10-26 for 20 d (Toronto)
Post-trial decisions: 2021 FC 4 (Phelan), 2021 FC 7 (Phelan)
- ALLERGAN INC. v. SANDOZ CANADA INC. ET AL
T-2023-18 – Patented Medicines (NOC) Regulations [Actions] – Silodosin
2020-10-26 for 5 d (Toronto)
Post-trial decisions: 2020 FC 1047 (Barnes), 2020 FC 1189 (Crampton), 2021 FC 186 (Crampton)
- GUEST TEK INTERACTIVE ENTERTAINMENT LTD. v. NOMADIX, INC.
T-448-17 – Patent Infringement
2020-09-28 for 14 d (Calgary) and 2020-10-27 for 2 d (Calgary)
Post-trial decisions: 2021 FC 276 (McHaffie), 2021 FC 848 (McHaffie)
Interlocutory decisions: 2018 FC 818 (Tabib), 2020 FC 860 (McHaffie)
- TEVA CANADA INNOVATION ET AL. v. PHARMASCIENCE ET AL.
T-2182-18 – Patented Medicines (NOC) Regulations [Actions] – Glatiramer
2020-09-21 for 10 d (Toronto) and 2020-10-14 for 2 d (Toronto) and 2020-10-21 for 2 d (Toronto)
Post-trial decisions: 2020 FC 1158 (Kane)
Interlocutory decisions: 2019 FC 595 (Tabib), 2019 FC 1394 (Tabib)
- TEVA CANADA INNOVATION AND OTHERS v. PHARMASCIENCE INC. AND OTHERS
T-2183-18 – Patented Medicines (NOC) Regulations [Actions] – Glatiramer
2020-09-21 for 10 d (Toronto) and 2020-10-14 for 2 d (Toronto) and 2020-10-21 for 2 d (Toronto)
Post-trial decisions: 2020 FC 1158 (Kane), 2021 FC 367 (Southcott)
- BRISTOL-MYERS SQUIBB CANADA CO. ET AL v. SANDOZ CANADA INC.
T-503-19 – Patented Medicines (NOC) Regulations [Actions] – Apixaban
2020-09-14 for 17 d (Toronto) and 2020-10-15 for 2 d (Toronto)
Post-trial decisions: 2021 FC 1 (Zinn), 2020 FC 897 (Zinn), 2021 FC 354 (Zinn)
- BRISTOL-MYERS SQUIBB CANADA CO. EL AL v. SANDOZ CANADA INC.
T-504-19 – Patented Medicines (NOC) Regulations [Actions] – Apixaban
2020-09-14 for 17 d (Toronto) and 2020-10-15 for 2 d (Toronto)
Post-trial decisions: 2021 FC 1 (Zinn), 2020 FC 897 (Zinn), 2021 FC 354 (Zinn)
- BRISTOL-MYERS SQUIBB CANADA CO. ET AL v. PHARMASCIENCE
T-97-19 – Patented Medicines (NOC) Regulations [Actions] – Apixaban
2020-09-14 for 17 d (Toronto) and 2020-10-15 for 2 d (Toronto)
Post-trial decisions: 2021 FC 1 (Zinn), 2020 FC 897 (Zinn), 2021 FC 354 (Zinn), 2023 FC 1023 (Morgan)
- BRISTOL-MYERS SQUIBB CANADA CO. ET AL v. PHARMASCIENCE INC.
T-98-19 – Patented Medicines (NOC) Regulations [Actions] – Apixaban
2020-09-14 for 17 d (Toronto) and 2020-10-15 for 2 d (Toronto)
Post-trial decisions: 2021 FC 1 (Zinn), 2020 FC 897 (Zinn), 2021 FC 354 (Zinn), 2023 FC 1023 (Morgan)
- JASON SWIST ET AL v. MEG ENERGY CORP.
T-1069-14 – Patent Infringement
2020-07-20 for 10 d (Toronto) and 2020-09-24 for 2 d (Toronto) and 2020-10-13 for 2 d (Toronto)
Post-trial decisions: 2021 FC 10 (Fothergill), 2021 FC 198 (Fothergill)
Interlocutory decisions: 2020 FC 759 (Fothergill)
- BAYER INC. et al v. APOTEX INC.
T-2093-18 – Patented Medicines (NOC) Regulations [Actions] – Rivaroxaban
2020-09-01 for 11 d (Ottawa) and 2020-10-06 for 4 d (Ottawa)
Post-trial decisions: 2019 FC 1370 (Pentney)
Interlocutory decisions: 2019 FC 191 (Tabib), 2019 FC 1039 (Pentney), 2020 FC 325 (Tabib), 2020 FC 866 (Pentney)
- BAYER INC. and BAYER INTELLECTUAL PROPERTY GMBH v. TEVA CANADA LMT.
T-1960-18 – Patented Medicines (NOC) Regulations [Actions] – Rivaroxaban
2020-09-01 for 11 d (Ottawa)
Post-trial decisions: 2019 FC 1370 (Pentney)
Interlocutory decisions: 2019 FC 191 (Tabib), 2019 FC 1039 (Pentney), 2020 FC 325 (Tabib)
- BIOGEN CANADA INC ET AL v. TARO PHARMACEUTICALS INC
T-1163-18 – Patented Medicines (NOC) Regulations [Actions] – Fampridine
2020-03-02 for 10 d (Toronto)
Post-trial decisions: 2020 FC 621 (Manson), 2022 FCA 143 (Gauthier, Gleason, Rivoalen)
Interlocutory decisions: 2018 FC 1034 (Tabib), 2019 FC 942 (Tabib)
- BIOGEN CANADA INC. et al. v. PHARMASCIENCE INC.
T-220-19 – Patented Medicines (NOC) Regulations [Actions] – Fampridine
2020-03-02 for 10 d (Toronto)
Post-trial decisions: 2020 FC 621 (Manson), 2022 FCA 143 (Gauthier, Gleason, Rivoalen)
Interlocutory decisions: 2019 FC 942 (Tabib)
- BAUER HOCKEY LTD. v. SPORT MASKA INC. ET AL
T-546-12 – Patent Infringement
2020-02-03 for 25 d (Montréal)
Post-trial decisions: 2020 FC 624 (Grammond), 2020 FC 862 (Grammond)
Interlocutory decisions: 2018 FC 828 (Steele), 2020 FC 212 (Grammond)
- JANSSEN INC. ET AL v. TEVA CANADA LIMITED
T-353-18 – Patented Medicines (NOC) Regulations [Actions] – Paliperidone
2020-02-03 for 15 d (Toronto)
Post-trial decisions: 2020 FC 87 (Manson), 2020 FC 593 (Manson), 2022 FC 62 (Manson), 2022 FC 107 (Manson), 2022 FC 269 (Manson), 2022 FC 1218 (Manson), 2023 FC 912 (Manson), 2023 FC 1464 (Morgan)
Interlocutory decisions: 2019 FC 1309 (Manson)
- ELI LILLY CANADA INC. ET AL. v. TEVA CANADA LIMITED
T-1631-16 – Patent Infringement – Tadalafil
2019-12-05 for 12 d (Ottawa) and 2020-02-03 for 5 d (Ottawa)
Post-trial decisions: 2020 FC 816 (St-Louis), 2022 FC 1398 (St-Louis), 2023 FC 782 (St-Louis), 2023 FC 9 (St-Louis)
Interlocutory decisions: 2019 FC 884 (Tabib)
- AMGEN INC. ET AL v. PFIZER CANADA ULC
T-741-18 – Patented Medicines (NOC) Regulations [Actions] – Filgrastim
2020-01-20 for 10 d (Toronto) and 2020-02-06 for 2 d (Toronto)
Post-trial decisions: 2020 FC 522 (Southcott)
Interlocutory decisions: 2018 FC 1078 (Milczynski)
- ELI LILLY CANADA INC. ET AL v. PHARMASCIENCE INC.
T-1623-16 – Patent Infringement – Tadalafil
2019-12-05 for 12 d (Ottawa)
Post-trial decisions: 2020 FC 816 (St-Louis), 2022 FC 1398 (St-Louis), 2023 FC 779 (St-Louis)
Interlocutory decisions: 2019 FC 884 (Tabib)
- ELI LILLY CANADA INC. ET AL. v. MYLAN PHARMACEUTICALS ULC
T-1627-16 – Patent Infringement – Tadalafil
2019-12-05 for 12 d (Ottawa) and 2020-01-20 for 5 d (Ottawa)
Post-trial decisions: 2020 FC 814 (St-Louis), 2020 FC 816 (St-Louis), 2022 FC 1398 (St-Louis), 2023 FC 780 (St-Louis), 2023 FC 13 (St-Louis)
Interlocutory decisions: 2019 FC 884 (Tabib)
- ELI LILLY CANADA INC., ELI LILLY AND COMPANY ET AL. v. APOTEX INC.
T-1632-16 – Patent Infringement – Tadalafil
2019-12-05 for 12 d (Ottawa) and 2020-01-13 for 5 d (Ottawa)
Post-trial decisions: 2020 FC 814 (St-Louis), 2020 FC 816 (St-Louis), 2023 FC 3 (St-Louis), 2022 FC 1398 (St-Louis), 2023 FC 783 (St-Louis)
Interlocutory decisions: 2019 FC 884 (Tabib)
- BIOFERT MANUFACTURING INC. v. AGRISOL MANUFACTURING INC. and Others
T-377-16 – Trade Mark Infringement
2019-11-25 for 14 d (Vancouver) and 2020-01-08 for 2 d (Vancouver)
Post-trial decisions: 2020 FC 501 (McVeigh), 2020 FC 379 (McVeigh)
2019
- BOMBARDIER RECREATIONAL PRODUCTS INC. v. ARCTIC CAT, INC.
T-2025-11 – Patent Infringement
2015-02-02 for 44 d (Montréal) and 2015-04-13 for 5 d (Montréal) and 2019-11-06 for 2 d (Montréal)
Post-trial decisions: 2020 FC 691 (Roy), 2020 FC 946 (Roy)
Interlocutory decisions: 2017 FC 207 (Roy)
- SEEDLINGS LIFE SCIENCE VENTURES,LLC V. PFIZER CANADA ULC / PFIZER CANADA SRI
T-608-17 – Patent Infringement
2019-10-21 for 15 d (Ottawa)
Post-trial decisions: 2020 FC 1 (Grammond), 2020 FC 505 (Grammond)
Interlocutory decisions: 2017 FC 826 (Tabib), 2018 FC 443 (Tabib), 2018 FC 956 (Ahmed)
- Alexander Stross v. Trend Hunter Inc., Jeremy Gutsche
T-130-18 – Copyright Infringement [Actions]
2019-10-23 for 1.3 d (Toronto)
Post-trial decisions: 2020 FC 201 (Furlanetto), 2021 FC 955 (Fuhrer)
- ELI LILLY AND CO. ET AL v. APOTEX INC.
T-1321-97 – Patent Infringement – Cefaclor
2019-09-18 for 2 d (Toronto)
Post-trial decisions: 2019 FC 1463 (Zinn)
Interlocutory decisions: 2007 FC 367 (Hughes), 2007 FC 1041 (Hughes), 2008 FC 892 (Gauthier), 2009 FC 991 (Gauthier), 2011 FC 1143 (Gauthier), 2014 FC 1254 (Zinn)
- ROGERS COMMUNICATIONS PARTNERSHIP ET AL AND SOCIETY OF COMPOSERS ET AL
T-2046-12 – Copyright Infringement [Actions]
2019-09-03 for 5 d (Toronto) and 2019-09-12 for 2 d (Toronto)
Post-trial decisions: 2021 FC 207 (Lafrenière)
Interlocutory decisions: 2015 FC 286 (O’Reilly)
- LOBLAWS INC. v. COLUMBIA INSURANCE COMPANY ET AL
T-548-18 – Trade Mark Infringement
2019-05-06 for 5 d (Toronto) and 2019-05-16 for 2 d (Toronto)
Post-trial decisions: 2019 FC 961 (Southcott), 2019 FC 1434 (Southcott)
- WENGER S.A. ET AL v. TRAVELWAY GROUP INTERNATIONAL INC.
T-1380-13 – S. 18.1 Application for Judicial Review
Post-trial decisions: 2019 FC 1104 (St-Louis)
Interlocutory decisions: 2016 FC 347 (St-Louis)
- 3469051 CANADA INC. c. AXIS HEATING AND AIR CONDITIONING INC.
T-2532-14 – Trade Mark Infringement
2018-12-11 for 1 d (Montréal) and 2019-04-01 for 3 d (Montréal)
Post-trial decisions: 2019 CF 1103 (Roy)
- AUX SABLE LIQUID PRODUCTS LP et al. v. JL ENERGY TRANSPORTATION INC.
T-1612-16 – Patent Infringement
2019-03-11 for 10 d (Calgary)
Post-trial decisions: 2019 FC 581 (Southcott), 2019 FC 788 (Southcott)
- TENSAR TECHNOLOGIES LTD ET AL v. ENVIRO-PRO GEOSYNTHETICS LTD.
T-1930-13 – Patent Infringement
2019-02-04 for 10 d (Montréal)
Post-trial decisions: 2019 FC 277 (Manson)
2018
- LANTECH.COM, LLC v. WULFTEC INTERNATIONAL INC.
T-1396-13 – Patent Infringement
2018-12-03 for 8 d (Montréal)
Settlement post trial.
Interlocutory decisions: 2018 FC 41 (Annis)
- WESTERN OILFIELD EQUIPMENT RENTALS LTD v. M-I LLC
T-1056-15 – Patent Impeachment
2018-10-22 for 20 d (Calgary)
Post-trial decisions: 2019 FC 1606 (O’Reilly)
- WESTERN DRIVING ACADEMY OF LONDON INC. v. WESTERN CITY DRIVING SCHOOL INC.
T-700-16 – Trade Mark Infringement
2018-10-23 for 1 d (Toronto)
Waiting for trial decision from trial judge, Justice Pentney.
- PYRRHA DESIGN INC. v. PLUM AND POSEY INC. ET AL
T-2022-13 – Copyright Infringement [Actions]
2018-10-01 for 7 d (Calgary)
Post-trial decisions: 2019 FC 129 (Phelan)
- CAMSO INC. v. SOUCY INTERNATIONAL INC. ET AL
T-2338-14 – Patent Infringement
2018-09-10 for 27 d (Montréal)
Post-trial decisions: 2019 FC 255 (Locke), 2019 CF 816 (Locke)
Interlocutory decisions: 2016 FC 1116 (Roy)
- LUC BESSETTE v. ATTORNEY GENERAL OF QUEBEC ET AL
T-975-16 – Patent Infringement
2018-05-28 for 10 d (Montréal)
Post-trial decisions: 2019 CF 393 (LeBlanc), 2023 FC 81 (McHaffie)
- APOTEX INC. v. SHIRE LLC ET AL
T-1056-16 – Patent Impeachment – Lisdexamfetamine
2018-04-16 for 20 d (Toronto)
Post-trial decisions: 2018 FC 637 (Fothergill), 2018 FC 1106 (Fothergill)
Interlocutory decisions: 2016 FC 1267 (Tabib), 2016 FC 1099 (Tabib), 2017 FC 831 (Tabib), 2017 FC 139 (Strickland)
- SHIRE PHARMA CANADA ULC v. APOTEX INC. ET AL.
T-998-16 – S. 18.1 Patented Medicines (Notice of Compliance) Regulations – Lisdexamfetamine
2018-04-16 for 20 d (Toronto)
Post-trial decisions: 2018 FC 637 (Fothergill), 2018 FC 1106 (Fothergill)
Interlocutory decisions: 2016 FC 1099 (Tabib), 2017 FC 139 (Strickland)
- TEVA CANADA LIMITED v. JANSSEN INC. ET AL.
T-944-15 – PMNOC – Section 8 – Bortezomib
2018-01-29 for 30 d (Ottawa)
Post-trial decisions: 2018 FC 754 (Locke), 2018 FC 1175 (Locke)
Interlocutory decisions: 2016 FC 318 (Diner), 2017 FC 437 (Tabib), 2017 FC 434 (Locke)
- APOTEX INC. v. ASTRAZENECA CANADA INC.
T-389-11 – PMNOC – Section 8 – Esomeprazole
2017-05-08 for 30 d (Toronto) and 2018-01-11 for 1 d (Toronto)
Post-trial decisions: 2018 FC 181 (Locke)
Interlocutory decisions: 2016 FC 552 (Tabib), 2017 FC 545 (Locke)
2017
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA ET AL v. I-MED PHARMA INC.
T-300-16 – Patent Infringement
2017-12-04 for 10 d (Montréal)
Post-trial decisions: 2018 FC 164 (Manson)
Interlocutory decisions: 2016 FC 350 (Russell), 2016 FC 975 (Lafrenière)
- GEORGETOWN RAIL EQUIPMENT COMPANY v. RAIL RADAR INC.ET AL
T-896-15 – Patent Infringement
2017-11-20 for 9 d (Toronto) and 2017-12-04 for 1 d (Toronto)
Post-trial decisions: 2018 FC 70 (Fothergill), 2020 FC 64 (Fothergill), 2020 FC 1188 (Fothergill), 2023 FC 347 (Morgan)
- CLEARVIEW PLUMBING & HEATING LTD. ET AL v. CLOCKWORK IP, LLC ET AL.
T-1569-13 – Trade Mark Infringement
2017-11-06 for 5 d (Calgary)
Post-trial decisions: 2018 FC 169 (McVeigh)
- ANDREW COLLETT v. NORTHLAND ART COMPANY LTD., ET AL
T-60-16 – Copyright Infringement [Actions]
2017-11-06 for 2 d (Toronto)
Post-trial decisions: 2018 FC 269 (Gleeson)
- 907687 ONTARIO INC. v. ABDUL SHOKOUR, ET AL
T-111-13 – Copyright Infringement [Actions]
2017-10-16 for 4 d (Toronto) and 2017-10-16 for 3 d (Toronto) and 2017-10-16 for 2 d (Toronto) and 2017-10-16 for 1 d (Toronto)
Post-trial decisions: 2017 FC 969 (Fothergill)
- MIPS AB v. BAUER HOCKEY LTD. ET AL
T-56-15 – Patent Impeachment
2017-09-05 for 32 d (Montréal) and 2017-09-05 for 32 d (Montréal) and 2017-09-05 for 32 d (Montréal) and 2017-09-05 for 32 d (Montréal)
Post-trial decisions: 2018 FC 485 (Gagné)
- HUMAN CARE CANADA INC. v. EVOLUTION TECHNOLOGIES INC.
T-1556-12 – Patent Infringement
2017-09-05 for 15 d (Toronto)
Post-trial decisions: 2018 FC 1302 (Elliott), 2018 FC 1304 (Elliott)
- SAFE GAMING SYSTEM INC. v. ATLANTIC LOTTERY CORPORATION ET AL
T-1043-12 – Patent Infringement
2017-05-23 for 14 d (Toronto) and 2017-06-22 for 1 d (Toronto)
Post-trial decisions: 2018 FC 542 (McVeigh), 2018 FC 871 (McVeigh)
Interlocutory decisions: 2013 FC 217 (Aronovitch)
- THE STORK MARKET INC., ET AL v. 1736735 ONTARIO INC., ET AL
T-1447-11 – Trade Mark Infringement
2017-06-12 for 2 d (Toronto)
Post-trial decisions: 2017 FC 779 (Southcott)
- ASTRAZENECA CANADA INC. ET AL v. APOTEX INC.
T-1668-10 – Patent Infringement – Esomeprazole
2013-09-04 for 38 d (Toronto) and 2013-11-15 for 4 d (Toronto) and 2017-05-08 for 30 d (Toronto)
Post-trial decisions: 2017 FC 545 (Locke), 2018 FC 181 (Locke), 2018 FC 185 (Locke)
Interlocutory decisions: 2011 FC 505 (Crampton), 2014 FC 638 (Rennie)
- DARIN GRENKE ET AL v. DNOW CANADA ULC ET AL
T-1236-01 – Patent Infringement
2017-05-01 for 15 d (Toronto)
Post-trial decisions: 2018 FC 564 (Phelan), 2018 FC 565 (Phelan)
Interlocutory decisions: 2007 FC 396 (Lafrenière), 2008 FC 1271 (Mandamin), 2009 FC 449 (Phelan), 2009 FC 569 (Phelan), 2010 FC 602 (Phelan), 2010 FC 667 (Phelan), 2012 FC 76 (Phelan)
- ASTRAZENECA CANADA INC. ET AL v. APOTEX INC.
T-1409-04 – Patent Infringement – Omeprazole
2014-04-07 for 40 d (Toronto) and 2014-06-23 for 4 (Toronto) and 2017-02-13 for 40 d (Toronto) and 2017-04-24 for 4 d (Toronto)
Post-trial decisions: 2017 FC 378 (Barnes), 2017 FC 726 (Barnes)
Interlocutory decisions: 2008 FC 1301 (Hughes), 2011 FC 862 (Hughes), 2011 FC 598 (Mosley), 2015 FC 322 (Barnes), 2015 FC 671 (Barnes), 2016 FC 865 (Zinn)
- ASTRAZENECA AB ET AL v. APOTEX INC.
T-1890-11 – Patent Infringement – Omeprazole
2014-04-07 for 40 d (Toronto) and 2014-06-23 for 4 (Toronto) and 2017-02-13 for 40 d (Toronto) and 2017-04-24 for 4 d (Toronto)
Post-trial decisions: 2017 FC 378 (Barnes), 2017 FC 726 (Barnes)
Interlocutory decisions: 2015 FC 322 (Barnes), 2015 FC 671 (Barnes), 2016 FC 865 (Zinn)
- APOTEX INC. v. ASTRAZENECA CANADA INC.
T-2300-05 – PMNOC – Section 8 – Omeprazole
2012-03-19 for 15 d (Toronto) and 2017-02-13 for 40 d (Toronto) and 2017-04-24 for 4 d (Toronto)
Post-trial decisions: 2017 FC 726 (Barnes)
Interlocutory decisions: 2007 FC 696 (Shore), 2009 FC 120 (Kelen), 2012 FC 559 (Hughes)
- TEVA CANADA LIMITED v. PFIZER CANADA INC.
T-1844-07 – PMNOC – Section 8 – Venlafaxine
2014-01-13 for 15 d (Ottawa) and 2017-04-05 for 1 d (Toronto)
Post-trial decisions: 2017 FC 526 (Zinn), 2017 FC 610 (Zinn)
Interlocutory decisions: 2011 FC 1169 (Hughes), 2011 FC 1442 (Hughes), 2014 FC 248 (Zinn), 2014 FC 634 (Zinn)
- RAPID COMPLETIONS LLC ET AL. v. BAKER HUGHES CANADA COMPANY
T-1569-15 – Patent Infringement
2017-02-06 for 18 d (Calgary) and 2017-03-07 for 3 d (Toronto)
Post-trial decisions: 2017 FC 1111 (O’Reilly), 2020 FC 68 (O’Reilly), T-1569-15 (Aalto), 2021 FC 986 (Fuhrer)
- PACKERS PLUS ENERGY SERVICES INC ET AL v WEATHERFORD INTERNATIONAL PLC ET AL
T-1728-15 – Patent Infringement
2017-02-06 for 18 d (Calgary) and 2017-03-07 for 3 d (Toronto)
Post-trial decisions: 2017 FC 1111 (O’Reilly), 2020 FC 68 (O’Reilly), T-1569-15 (Aalto), 2021 FC 986 (Fuhrer)
- PACKERS PLUS ENERGY SERVICES INC. v. ESSENTIAL ENERGY SERVICES LTD. ET AL
T-1741-13 – Patent Infringement
2017-02-06 for 18 d (Calgary) and 2017-03-07 for 3 d (Toronto)
Post-trial decisions: 2017 FC 1111 (O’Reilly), 2020 FC 68 (O’Reilly), T-1569-15 (Aalto), 2021 FC 986 (Fuhrer)
- PACKERS PLUS ENERGY SERVICES INC. ET AL v. RESOURCE WELL COMPLETION TECH.
T-2088-15 – Patent Infringement
2017-02-06 for 18 d (Calgary) and 2017-03-07 for 3 d (Toronto)
Post-trial decisions: 2017 FC 1111 (O’Reilly), 2020 FC 68 (O’Reilly)
- DIAGEO CANADA INC v. HEAVEN HILL DISTILLERIES INC ET AL
T-740-14 – Trade Mark Infringement
2017-02-06 for 8 d (Toronto)
Post-trial decisions: 2017 FC 571 (Boswell), 2017 FC 624 (Boswell), 2017 FC 738 (Boswell)
2016
- CASELLA WINES PTY LIMITED v. CONSTELLATION BRANDS CANADA, INC.
T-1594-13 – Trade Mark Infringement
2016-12-05 for 7 d (Montréal)
Settlement post trial.
Interlocutory decisions: 2015 FC 403 (Harrington)
- FRAC SHACK INC and FRAC SHACK INTERNATIONAL INC v. AFD PETROLEUM LTD
T-2149-14 – Patent Infringement
2016-11-28 for 12 d (Edmonton)
Post-trial decisions: 2017 FC 104 (Manson), 2017 FC 274 (Manson), 2018 FC 1047 (Manson)
- UNITED AIRLINES, INC. v. JEREMY COOPERSTOCK
T-2084-12 – Trade Mark Infringement
2016-12-05 for 4 d (Montréal)
Post-trial decisions: 2017 FC 616 (Phelan)
Interlocutory decisions: 2014 FC 157 (Roy)
- LAINCO INC. c. COMMISSION SCOLAIRE DES BOIS-FRANCS ET AL
T-941-13 – Copyright Infringement [Actions]
2016-10-17 for 10 d (Montréal)
Post-trial decisions: 2017 CF 825 (LeBlanc), 2018 CF 186 (LeBlanc)
- MEDIATUBE CORP. AND NORTHVU INC. v. BELL CANADA
T-705-13 – Patent Infringement
2016-09-12 for 32 d (Toronto)
Post-trial decisions: 2017 FC 6 (Locke), 2017 FC 495 (Locke), 2018 FC 355 (Locke)
Interlocutory decisions: 2014 FC 237 (Kane), 2015 FC 391 (Aalto), 2016 FC 1066 (Locke)
- EXCALIBRE OIL TOOLS LTD ET AL v. ADVANTAGE PRODUCTS INC ET AL
T-1741-08 – Patent Impeachment
2016-09-12 for 15 d (Calgary) and 2016-10-03 for 2 d (Calgary)
Post-trial decisions: 2016 FC 1279 (Manson), 2016 FC 1130 (Manson)
- ADVANTAGE PRODUCTS INC. ET AL v. EXCALIBRE OIL TOOLS LTD ET AL
T-1946-09 – Patent Infringement
2016-09-12 for 15 d (Calgary) and 2016-10-03 for 2 d (Calgary)
Post-trial decisions: 2016 FC 1279 (Manson), 2016 FC 1130 (Manson)
- 139504 ONTARIO LTD., OPERATING AS BLACKLOCK’S REPORTER v. AGC
T-1391-14 – Copyright Infringement [Actions]
2016-09-19 for 5 d (Ottawa)
Post-trial decisions: 2016 FC 1255 (Barnes), 2016 FC 1400 (Barnes)
- COROCORD RAUMNETZ GMBH ET AL v. DYNAMO INDUSTRIES INC.
T-339-14 – Copyright Infringement [Actions]
2016-09-12 for 5 d (Ottawa)
Post-trial decisions: 2016 FC 1369 (St-Louis)
- THE CANADIAN COPYRIGHT LICENSING AGENCY v. YORK UNIVERSITY
T-578-13 – Copyright Infringement [Actions]
2016-05-16 for 15 d (Toronto) and 2016-06-22 for 3 h (Ottawa) and 2016-06-23 for 3 h (Ottawa) and 2016-06-24 for 1 d (Ottawa)
Post-trial decisions: 2017 FC 669 (Phelan)
- EUROCOPTER c. BELL HELICOPTER TEXTRON CANADA LIMITÉE
T-737-08 – Patent Infringement
2011-01-17 for 25 d (Montréal) and 2011-02-24 for 2 d (Montréal) and 2016-05-30 for 10 d (Montréal) and 2016-05-30 for 4 d (Montréal)
Post-trial decisions: 2017 FC 170 (Martineau)
Interlocutory decisions: 2009 CF 836 (Morneau), 2009 CF 1141 (Tremblay-Lamer), 2009 CF 1142 (Tremblay-Lamer), 2009 CF 1021 (Morneau), 2010 CF 293 (Morneau), 2010 CF 579 (Martineau), 2010 FC 1328 (Martineau), 2012 FC 113 (Martineau), 2012 FC 842 (Martineau)
- ELI LILLY CANADA INC. ET AL v. NOVOPHARM LIMITED
T-1048-07 – Patent Infringement – Olanzapine
2011-01-19 for 2 d (Toronto) and 2016-05-02 for 18 d (Toronto)
Post-trial decisions: 2017 FC 88 (O’Reilly)
Interlocutory decisions: 2007 FC 1126 (Gauthier), 2007 FC 1195 (Tabib), 2008 FC 281 (Lemieux), 2009 FC 1018 (O’Reilly), 2010 FC 241 (Zinn), 2011 FC 1288 (O’Reilly), 2013 FC 677 (Tabib), 2015 FC 801 (Annis)
- POLLARD BANKNOTE LIMITED v. BABN TECHNOLOGIES CORP.
T-407-14 – Patent Impeachment
2016-05-02 for 15 d (Toronto)
Post-trial decisions: 2016 FC 883 (Locke), 2016 FC 1193 (Locke)
- JANSSEN-ORTHO LLC, ET AL v. TEVA CANADA LIMITED ET AL
T-2056-11 – Patent Infringement
2016-04-04 for 15 d (Toronto)
Post-trial decisions: 2016 FC 593 (Hughes)
- JANSSEN INC. AND DAIICHI ET AL. v. TEVA CANADA LIMITED
T-2175-04 – Patent Infringement – Levofloxacin
2016-04-04 for 15 d (Toronto)
Post-trial decisions: 2016 FC 593 (Hughes)
Interlocutory decisions: 2006 FC 1333 (Hughes), 2006 FC 1234 (Hughes), 2011 FC 1480 (Hughes), 2012 FC 48 (Preston)
- TEVA CANADA LIMITED v. PFIZER CANADA INC. ET AL
T-1496-13 – PMNOC – Section 8 – Pregabalin
2016-03-21 for 20 d (Toronto)
Post-trial decisions: 2017 FC 332 (Phelan)
- CANPLAS INDUSTRIES LTD. v. AIRTURN PRODUCTS INC ET AL
T-366-11 – Patent Infringement
2016-02-29 for 2 d (Toronto) and 2016-03-02 for 1 d (Toronto)
Discontinuance filed post trial.
Interlocutory decisions: 2016 FC 109 (Barnes)
- CANPLAS INDUSTRIES LTD. v. MERIT PRECISION MOULDING LIMITED
T-719-14 – Patent Infringement
2016-02-29 for 2 d (Toronto) and 2016-03-02 for 1 d (Toronto)
Discontinuance filed post trial.
Interlocutory decisions: 2016 FC 109 (Barnes)
- STANDARD INNOVATION CORPORATION v. LELOI AB ET AL.
T-925-12 – Patent Infringement
2016-02-01 for 1 d (Ottawa)
Unpublished trial decision.
- BAYER INC. ET AL v. APOTEX INC.
T-1368-14 – Patent Infringement – Drospirenone
2016-01-11 for 30 d (Toronto)
Post-trial decisions: 2016 FC 1013 (Fothergill), 2016 FC 1192 (Fothergill), 2017 FC 775 (Fothergill)
- BAYER INC. ET AL v. COBALT PHARMACEUTICALS COMPANY
T-1379-13 – Patent Infringement – Drospirenone
2016-01-11 for 30 d (Toronto)
Post-trial decisions: 2016 FC 1013 (Fothergill), 2016 FC 1192 (Fothergill), 2017 FC 775 (Fothergill)
- BAYER INC. ET AL v. APOTEX INC.
T-1468-13 – Patent Infringement – Drospirenone
2016-01-11 for 30 d (Toronto)
Post-trial decisions: 2016 FC 1013 (Fothergill), 2016 FC 1192 (Fothergill), 2017 FC 775 (Fothergill)
- ARCTIC CAT INC. v. BOMBARDIER RECREATIONAL PRODUCTS INC.
T-1353-13 – Patent Infringement
2015-09-14 for 20 d (Toronto) and 2016-01-25 for 4 d (Ottawa) and 2016-02-01 for 2 d (Ottawa)
Post-trial decisions: 2016 FC 1047 (Roy)
Interlocutory decisions: 2015 FC 938 (Tabib)
- UPONOR AB v. HEATLINK GROUP INC. ET AL
T-496-11 – Patent Infringement
2016-01-11 for 10 d (Calgary)
Post-trial decisions: 2016 FC 320 (Manson)
2015
- VENNGO INC. v. CONCIERGE CONNECTION INC. ET AL
T-467-11 – Trade Mark Infringement
2015-11-09 for 7 d (Toronto)
Post-trial decisions: 2015 FC 1338 (Manson)
- AFX LICENSING CORP. v. HJC AMERICA, INC. ET AL
T-1110-12 – Industrial Design Infringement
2015-11-02 for 3 d (Toronto)
Post-trial decisions: 2016 FC 435 (Diner)
- AFX LICENSING CORPORATION v. ROYAL DISTRIBUTING INC.
T-491-14 – Trade Mark Infringement
2015-11-02 for 3 d (Toronto)
Post-trial decisions: 2016 FC 435 (Diner)
- RESPONSIVE BRANDS INC. v. 2248003 ONTARIO INC. ET AL
T-64-11 – Trade Mark Infringement
2015-10-19 for 3.3 d (Toronto) and 2015-11-03 for 3 h (Toronto)
Post-trial decisions: 2016 FC 355 (Boswell)
- SCOTT TECHNOLOGIES, INC. v. 783825 ALBERTA Ltd. et al
T-2041-12 – Trade Mark Infringement
2015-09-14 for 5 d (Calgary)
Post-trial decisions: 2015 FC 1336 (Zinn)
- MATHIEU CROCHETIÈRE-BROUSSEAU c. 9107-0235 QUÉBEC INC.(GRATTEX) ET AL
T-538-12 – Copyright Infringement [Actions]
2015-04-28 for 2 d (Trois-Rivières)
Post-trial decisions: 2015 CF 1219 (LeBlanc)
- CARNOT RÉFRIGÉRATION c. TOROMONT INDUSTRIES LTD.
T-129-13 – Patent Infringement
2015-04-13 for 8 d (Montréal)
Discontinuance filed post trial.
- TOROMONT INDUSTRIES LTD v. CARNOT RÉFRIGÉRATION INC ET AL
T-393-13 – Patent Infringement
2015-04-13 for 8 d (Montréal)
Discontinuance filed post trial.
- DOMAINES PINNACLE INC. v. BEAM SUNTORY INC. ET AL
T-290-13 – Trade Mark Infringement
2015-04-13 for 5 d (Montréal)
Post-trial decisions: 2015 FC 680 (Martineau)
Interlocutory decisions: 2013 FC 831 (Boivin), 2013 FC 1051 (Morneau), 2013 FC 1199 (Roy)
- GILEAD SCIENCES, INC. ET AL v. IDENIX PHARMACEUTICALS, INC. ET AL
T-1156-12 – Patent Infringement
2015-01-12 for 15 d (Toronto) and 2015-02-02 for 5 d (Toronto) and 2015-02-09 for 3 d (Toronto)
Post-trial decisions: 2015 FC 1156 (Annis)
Interlocutory decisions: 2014 FC 391 (Mactavish)
2014
- ADIR and SERVIER CANADA INC. v. APOTEX INC. ET AL
T-1548-06 – Patent Infringement – Perindopril
2014-11-17 for 20 d (Toronto)
Post-trial decisions: 2015 FC 721 (Gagné), 2018 FC 346 (Gagné)
Interlocutory decisions: 2006 FC 1405 (Morneau), 2006 FC 1443 (Noël), 2006 FC 1493 (Snider), 2007 FC 344 (Snider), 2007 FC 837 (Snider), 2007 FC 1210 (Snider), 2008 FC 321 (Snider), 2008 FC 825 (Snider), 2008 FC 1070 (Snider)
- RED LABEL VACATIONS INC. (REDTAG.CA) v. 411 TRAVEL BUYS LIMITED
T-1399-09 – Trade Mark Infringement
2014-11-24 for 10 d (Toronto)
Post-trial decisions: 2015 FC 19 (Manson), 2015 FC 743 (Preston)
- APOTEX INC v. HER MAJESTY THE QUEEN
T-1930-98 – Others – Crown (v. Queen) [Actions] – Trazodone
2014-10-20 for 10 d (Toronto)
Post-trial decisions: 2014 FC 1087 (Hughes)
- SNF INC. v. CIBA SPECIALTY CHEMICALS WATER TREATMENTS LIMITED
T-1749-11 – Patent Impeachment
2014-09-29 for 25 d (Toronto)
Post-trial decisions: 2015 FC 997 (Phelan)
Interlocutory decisions: 2014 FC 616 (Phelan)
- PHILIP MORRIS PRODUCTS S.A. ET AL v. MARLBORO CANADA LTD. ET AL
T-1784-06 – Trade Mark Infringement
2010-01-18 for 13 d (Toronto) and 2010-02-09 for 2 d (Toronto) and 2010-03-22 for 3 d (Toronto) and 2010-04-06 for 4 d (Toronto) and 2014-09-24 for 3 d (Montréal)
Post-trial decisions: 2015 FC 364 (de Montigny)
Interlocutory decisions: 2010 FC 1099 (de Montigny)
- ABBVIE CORP. ET AL v. JANSSEN INC.
T-1310-09 – Patent Infringement – Ustekinumab
2013-12-02 for 15 d (Toronto) and 2014-01-07 for 4 d (Toronto) and 2014-05-12 for 5 d (Toronto)
Post-trial decisions: 2014 FC 489 (Hughes), 2014 FC 863 (Brown)
Interlocutory decisions: 2013 FC 1148 (Hughes), 2014 FC 55 (Hughes), 2014 FC 178 (Hughes)
- HEAMAN PIPE BENDING INC. ET AL v. PROLINE PIPE EQUIPMENT INC.
T-1027-09 – Patent Infringement
2014-04-28 for 1 d (Edmonton)
Discontinuance filed post trial.
- E. MISHAN & SONS INC ET AL v. SUPERTEK CANADA INC ET AL
T-1112-13 – Patent Infringement
2014-03-24 for 8 d (Toronto)
Post-trial decisions: 2014 FC 326 (Hughes), 2016 FC 613 (Hughes), 2016 FC 986 (Hughes)
- APOTEX INC. v. GLAXOSMITHKLINE INC.
T-14-09 – S. 18.1 Patented Medicines (Notice of Compliance) Regulations – Valacyclovir
2014-01-13 for 36 d (Toronto)
Discontinuance filed post trial.
- GLAXOSMITHKLINE INC ET AL v. PHARMASCIENCE INC. ET AL
T-2101-09 – Patent Infringement – Valacyclovir
2014-01-13 for 36 d (Toronto)
Discontinuance filed post trial.
- PHARMASCIENCE INC v. GLAXOSMITHKLINE INC.
T-643-10 – PMNOC – Section 8 – Valacyclovir
2014-01-13 for 36 d (Toronto)
Discontinuance filed post trial.
2013
- THE DOW CHEMICAL COMPANY ET AL v. NOVA CHEMICALS CORPORATION
T-2051-10 – Patent Infringement
2013-09-09 for 38 d (Toronto) and 2013-09-09 for 20 d (Toronto)
Post-trial decisions: 2012 FC 754 (O’Keefe), 2014 FC 844 (O’Keefe), 2016 FC 91 (O’Keefe), 2017 FC 350 (Fothergill), 2017 FC 637 (Fothergill), 2017 FC 759 (Fothergill), 2016 FC 361 (Hughes), 2020 FCA 141 (Near, Stratas, Woods)
- H-D MICHIGAN, INC. ET AL v. JAMAL BERRADA ET AL
T-605-07 – Trade Mark Infringement
2013-09-09 for 15 d (Montréal)
Post-trial decisions: 2014 FC 207 (Scott), 2015 FC 189 (St-Louis)
Interlocutory decisions: 2007 FC 995 (Aalto)
- ABB TECHNOLOGY AG et al. v. HYUNDAI HEAVY INDUSTRIES CO., LTD.
T-735-11 – Patent Infringement
2013-06-10 for 10 d (Toronto) and 2013-06-10 for 2 d (Toronto)
Post-trial decisions: 2013 FC 947 (Barnes), 2013 FC 1050 (Barnes)
- JACQUES FORTIN ET AL c. GARAGE A.J.M. INC. ET AL
T-764-10 – Patent Infringement
2013-06-10 for 2 d (Alma) and 2013-06-13 for 1 d (Alma)
Waiting for trial decision from trial judge, .
- ELECTRICAL COMPONENTS CANADA, INC. v. PHILLIPS & TEMRO INDUSTRIES LTD.
T-1690-10 – Patent Infringement
2012-11-13 for 7 d (Toronto) and 2013-06-03 for 1 d (Toronto)
Waiting for trial decision from trial judge, Justice O’Keefe.
- YEHUDA PINTO v. BRONFMAN JEWISH EDUCATION CENTRE ET AL
T-1070-07 – Copyright Infringement [Actions]
2013-05-27 for 5 d (Montréal) and 2013-06-06 for 1 d (Montréal)
Post-trial decisions: 2013 FC 945 (Rennie)
- APOTEX INC. v. TAKEDA CANADA INC.
T-1786-08 – PMNOC – Section 8 – Pantoprazole
2013-02-18 for 15 d (Toronto) and 2013-05-21 for 3 d (Toronto)
Post-trial decisions: 2013 FC 1237 (Phelan)
Interlocutory decisions: 2011 FC 1441 (Simpson)
- ELI LILY CANADA INC ET AL v. APOTEX INC.
T-512-10 – Patent Infringement – Raloxifene
2013-04-08 for 1 d (Toronto)
Discontinuance filed during trial.
- ELI LILLY AND COMPANY ET AL v. APOTEX INC. ET AL
T-516-10 – Patent Infringement – Raloxifene
2013-04-08 for 1 d (Toronto)
Discontinuance filed post trial.
- APOTEX INC. v. ELI LILLY CANADA INC.
T-656-09 – PMNOC – Section 8 – Raloxifene
2013-04-08 for 1 d (Toronto)
Discontinuance filed during trial.
Interlocutory decisions: 2009 FC 693 (Tabib)
- OSMOSE-PENTOX INC. v. SOCIÉTÉ LAURENTIDE INC.
T-697-02 – Trade Mark Infringement
2013-05-06 for 5 d (Montréal) and 2013-05-06 for 5 d (Montréal) and 2013-05-06 for 4 d (Montréal)
Post-trial decisions: 2013 FC 626 (Martineau)
Interlocutory decisions: 2005 FC 1689 (Morneau), 2007 FC 242 (Hugessen), 2007 CF 504 (Morneau), 2006 FC 386 (de Montigny), 2010 FC 676 (Martineau)
- MERCK & CO. INC. ET AL v. APOTEX INC. ET AL
T-1272-97 – Patent Infringement – Lovastatin
2010-02-01 for 48 d (Toronto) and 2010-05-17 for 5 d (Toronto) and 2013-04-08 for 8 d (Toronto) and 2013-05-01 for 3 d (Toronto)
Post-trial decisions: 2013 FC 751 (Snider)
Interlocutory decisions: 2008 FC 1121 (O’Keefe), 2010 FC 1265 (Snider), 2012 FC 454 (Rennie)
- ZERO SPILL SYSTEMS (INT’L) INC. ET AL v. 614248 ALBERTA LTD. ET AL
T-279-07 – Patent Infringement
2013-04-08 for 20 d (Edmonton)
Post-trial decisions: 2013 FC 616 (Barnes)
Interlocutory decisions: 2009 FC 70 (Blanchard)
- DISTRIMEDIC INC c. DISPILL INC ET AL
T-1591-05 – Patent Impeachment
2013-03-25 for 15 d (Montréal)
Post-trial decisions: 2013 FC 1043 (de Montigny)
Interlocutory decisions: 2006 FC 1229 (Teitelbaum), 2011 FC 410 (Preston)
2012
- TEVA CANADA LIMITED v. NYCOMED CANADA INC ET AL
T-368-08 – PMNOC – Section 8 – Pantoprazole
2012-11-19 for 8 d (Toronto)
Unpublished trial decision.
Interlocutory decisions: 2011 FC 109 (Mandamin), 2011 FC 1441 (Simpson)
- TEVA CANADA LIMITED v. NOVARTIS AG
T-2021-10 – Intellectual Property – Others [Actions] – Imatinib
2012-09-24 for 19 d (Toronto) and 2012-11-05 for 5 d (Toronto)
Post-trial decisions: 2013 FC 141 (Snider), 2012 FC 787 (Tabib)
- APOTEX INC. v. NOVARTIS AG
T-833-11 – Patent Infringement – Imatinib
2012-09-24 for 19 d (Toronto) and 2012-11-05 for 5 d (Toronto)
Post-trial decisions: 2013 FC 141 (Snider)
- APOTEX INC. v. MERCK & CO. INC. ET AL
T-1144-05 – PMNOC – Section 8 – Alendronate
2012-09-24 for 2 d (Toronto) and 2012-09-27 for 3 d (Toronto) and 2012-09-27 for 1 d (Toronto) and 2012-10-01 for 1 d (Toronto)
Post-trial decisions: 2012 FC 1235 (Hughes), 2012 FC 1418 (Hughes)
Interlocutory decisions: 2008 FC 1185 (Hughes)
- APOTEX INC. v. PFIZER CANADA INC.
T-825-06 – PMNOC – Section 8 – Azithromycin
2012-09-04 for 12 d (Toronto)
Post-trial decisions: 2013 FC 493 (O’Reilly)
- Bodum USE Inc. et al. v. Trudeau Corporation (1889) Inc.
T-735-07 – Industrial Design Infringement
2012-05-22 for 4 d (Montreal)
Post-trial decisions: 2012 FC 1128 (Boivin), 2013 CF 128 (Boivin)
Interlocutory decisions: 2012 FC 240 (de Montigny)
- WEATHERFORD CANADA LTD. ET AL v. CORLAC INDUSTRIES (1998) LTD. ET AL
T-380-01 – Patent Infringement
2012-02-13 for 1 d (Toronto)
Unpublished trial decision.
- APOTEX INC. v. SCHERING CORPORATION ET AL
T-1357-09 – PMNOC – Section 8 – Ramipril
2012-02-13 for 15 d (Toronto)
Post-trial decisions: 2012 FC 551 (Snider), 2012 FC 553 (Snider)
Interlocutory decisions: 2009 FC 1285 (Snider), 2010 FC 1209 (Simpson)
- CATHERINE LEUTHOLD v. CANADIAN BROADCASTING CORPORATION ET AL
T-299-05 – Copyright Infringement [Actions]
2012-02-06 for 8 d (Montréal)
Post-trial decisions: 2012 FC 748 (Scott), 2012 FC 1257 (Scott)
Interlocutory decisions: 2007 FC 7 (Morneau)
- SANOFI-AVENTIS CANADA INC. ET AL v. TEVA CANADA LIMITED
T-1161-07 – Patent Infringement – Ramipril
2012-01-16 for 15 d (Toronto)
Post-trial decisions: 2012 FC 552 (Snider), 2012 FC 551 (Snider)
Interlocutory decisions: 2009 FC 676 (Snider), 2009 FC 1139 (Snider), 2009 FC 1285 (Snider), 2010 FC 150 (Milczynski), 2010 FC 1210 (Simpson)
- VARCO CANADA LIMITED ET AL v. PASON SYSTEMS CORP ET AL
T-436-05 – Patent Infringement
2011-01-17 for 20 d (Toronto) and 2012-01-13 for 1 d (Toronto)
Post-trial decisions: 2013 FC 750 (Phelan)
Interlocutory decisions: 2009 FC 538 (Gibson), 2009 FC 555 (Mandamin), 2011 FC 467 (Phelan), 2011 FC 1140 (Phelan), 2011 FC 1318 (Phelan)
2011
- WENZEL DOWNHOLE TOOLS LTD. ET AL v. NATIONAL-OILWELL CANADA LTD ET AL
T-1327-05 – Patent Infringement
2011-09-19 for 19 d (Edmonton)
Post-trial decisions: 2011 FC 1323 (Snider)
Interlocutory decisions: 2010 FC 669 (Lafrenière), 2010 FC 966 (Snider)
- APOTEX INC. v. H. LUNDBECK A/S ET AL
T-575-04 – Patent Infringement – Citalopram
2011-09-12 for 15 d (Toronto)
Settlement post trial.
Interlocutory decisions: 2009 FC 419 (Beaudry), 2011 FC 88 (Tabib)
- HOLLICK SOLAR SYSTEMS LIMITED ET AL v. MATRIX ENERGY INC. ET AL
T-1791-07 – Patent Infringement
2011-09-06 for 10 d (Montréal)
Post-trial decisions: 2011 FC 1213 (Scott)
- APOTEX INC. v. SANOFI-AVENTIS
T-644-09 – Patent Infringement – Clopidogrel
2011-04-18 for 16 d (Toronto) and 2011-05-16 for 4 d (Toronto) and 2011-05-24 for 2 d (Ottawa) and 2011-05-30 for 2 d (Ottawa) and 2011-06-13 for 3 d (Ottawa)
Post-trial decisions: 2012 FC 318 (Boivin)
Interlocutory decisions: 2010 FC 77 (Tabib), 2010 FC 182 (Tabib), 2010 FC 481 (Tabib), 2010 FC 1022 (Campbell), 2010 FC 1282 (Boivin), 2011 FC 52 (de Montigny)
- SANOFI-AVENTIS ET AL v. APOTEX INC. ET AL
T-933-09 – Patent Infringement – Clopidogrel
2011-04-18 for 16 d (Toronto) and 2011-05-16 for 4 d (Toronto) and 2011-05-24 for 2 d (Ottawa) and 2011-05-30 for 2 d (Ottawa) and 2011-06-13 for 3 d (Ottawa)
Post-trial decisions: 2012 FC 318 (Boivin)
Interlocutory decisions: 2010 FC 77 (Tabib), 2010 FC 182 (Tabib), 2010 FC 481 (Tabib), 2010 FC 1022 (Campbell), 2010 FC 1282 (Boivin), 2011 FC 52 (de Montigny)
- 1429539 ONTARIO LIMITED v. CAFE MIRAGE INC ET AL
T-82-05 – Trade Mark – Passing Off
2011-01-31 for 10 d (Toronto)
Post-trial decisions: 2011 FC 1290 (Mandamin)
2010
- VALENCE TECHNOLOGY INC. v. PHOSTECH LITHIUM INC.
T-219-07 – Patent Infringement
2010-09-01 for 11 d (Montréal) and 2010-09-29 for 3 d (Toronto)
Post-trial decisions: 2011 FC 174 (Gauthier)
Interlocutory decisions: 2010 CF 12 (Lemieux)
- NOVOPHARM LIMITED v. ELI LILLY AND COMPANY
T-811-08 – Patent Impeachment – Atomoxetine
2010-05-11 for 20 d (Toronto)
Post-trial decisions: 2010 FC 915 (Barnes), 2010 FC 1154 (Barnes)
Interlocutory decisions: 2008 FC 840 (Aalto), 2010 FC 368 (Barnes)
- APOTEX INC. v. MERCK & CO. INC. ET AL
T-1169-01 – PMNOC – Section 8 – Lovastatin
2010-02-01 for 48 d (Toronto) and 2010-05-17 for 5 d (Toronto)
Post-trial decisions: 2010 FC 1264 (Snider), 2012 FC 620 (Snider)
- DRAGERWERK AG ET AL v. ALCOTEST QUEBEC INC ET AL
T-2088-07 – Trade Mark Infringement
2010-04-12 for 3 d (Montréal)
Discontinuance filed during trial.
- FREDERICK L. NICHOLAS v. ENVIRONMENTAL SYSTEMS ET AL
T-949-05 – Copyright Infringement [Actions]
2010-04-12 for 5 d (Toronto)
Post-trial decisions: 2010 FC 741 (Russell)
Interlocutory decisions: 2009 FC 1160 (Mosley)
- GLASTON SERVICES LTD. OY v. HORIZON GLASS & MIRROR LTD. ET AL
T-1108-07 – Patent Infringement
2010-03-23 for 1 d (Toronto)
Post-trial decisions: 2010 FC 1191 (Mandamin)
- HARMONY CONSULTING LTD. v. G.A. FOSS TRANSPORT LTD. ET AL
T-1269-05 – Copyright Infringement [Actions]
2010-01-27 for 2 d (Toronto)
Post-trial decisions: 2011 FC 340 (Heneghan), 2011 FC 540 (Heneghan)
- JAG FLOCOMPONENTS N A ET AL v. ARCHMETAL INDUSTRIES CORPORATION INC ET AL
T-1354-06 – Trade Mark Infringement
2010-01-18 for 10 d (Edmonton)
Post-trial decisions: 2010 FC 627 (Phelan)
- NIKE BAUER HOCKEY INC. ET AL v. EASTON SPORTS CANADA INC.
T-237-02 – Patent Infringement
2010-01-11 for 2 d (Montréal)
Post-trial decisions: 2010 FC 361 (Gauthier)
Interlocutory decisions: 2008 CF 666 (Morneau)